Literature DB >> 19146642

Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease.

H Hanyu1, T Sato, K Hirao, H Kanetaka, H Sakurai, T Iwamoto.   

Abstract

BACKGROUND AND
PURPOSE: To investigate whether there may be differences in the clinical course and changes in cognitive progression between dementia with Lewy bodies (DLB) and Alzheimer's disease (AD).
METHODS: We compared the time from the first visit to endpoints (discontinuation of visits because of admission, death, or institutionalization) between 56 patients with DLB and 111 patients with AD. Mini-Mental State Examination (MMSE) scores of patients were every 12 months examined up to 60 months.
RESULTS: Dementia with Lewy bodies had a significantly shorter time to reaching endpoints than those with AD (median time; 40 months vs. 52 months, P < 0.0001). The proportion of admission (or death) was significantly higher in DLB than in AD (30% vs. 14%, P < 0.05), while the difference in institutionalization in nursing homes did not reach statistical significance (25% vs. 17%). Rates of longitudinal MMSE score decline for DLB and AD groups were equivalent.
CONCLUSION: Dementia with Lewy bodies had a greater risk of admission (or death) because of most commonly fall-related injuries and bronchopneumonia than AD, but the two groups did not differ in rate of cognitive decline.

Entities:  

Mesh:

Year:  2009        PMID: 19146642     DOI: 10.1111/j.1468-1331.2008.02388.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  28 in total

1.  Dementia with lewy bodies: diagnosis and management for primary care providers.

Authors:  Melanie Zupancic; Aman Mahajan; Kamna Handa
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Lewy body dementia: the caregiver experience of clinical care.

Authors:  James E Galvin; John E Duda; Daniel I Kaufer; Carol F Lippa; Angela Taylor; Steven H Zarit
Journal:  Parkinsonism Relat Disord       Date:  2010-07       Impact factor: 4.891

3.  Risk of decline in functional activities in dementia with Lewy bodies and Alzheimer disease.

Authors:  Dawn P Gill; Thomas D Koepsell; Rebecca A Hubbard; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

4.  UPDATE ON DEMENTIA WITH LEWY BODIES.

Authors:  Stella Karantzoulis; James E Galvin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

5.  Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease.

Authors:  Kiren Ubhi; Kevin Peng; Stephanie Lessig; Jennilyn Estrella; Anthony Adame; Douglas Galasko; David P Salmon; Lawrence A Hansen; Claudia H Kawas; Eliezer Masliah
Journal:  Neurosci Lett       Date:  2010-09-21       Impact factor: 3.046

6.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

7.  Outcomes of Inpatient Treatment for Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease Versus Dementia With Lewy Bodies.

Authors:  Tatsuru Kitamura; Shinnichi Tochimoto; Maki Kitamura; Shuhei Madachi; Shoryoku Hino
Journal:  Prim Care Companion CNS Disord       Date:  2015-10-01

8.  Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age.

Authors:  G Roberts; J J Lloyd; J P M Kane; R Durcan; S Lawley; K Howe; G S Petrides; J T O'Brien; A J Thomas
Journal:  J Nucl Cardiol       Date:  2019-09-16       Impact factor: 5.952

9.  Advanced cognitive impairment among older nursing home residents.

Authors:  Tadeja Gracner; Patricia W Stone; Mansi Agarwal; Mark Sorbero; Susan L Mitchell; Andrew W Dick
Journal:  BMC Geriatr       Date:  2021-06-23       Impact factor: 3.921

10.  The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia.

Authors:  Kajsa Stubendorff; Dag Aarsland; Lennart Minthon; Elisabet Londos
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.